Xenetic Biosciences Inc (XBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,645 | -3,804 | -2,453 | -1,346 | -10,894 |
| Depreciation Amortization | 36 | 26 | 17 | 8 | 29 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -2,919 |
| Other Working Capital | 461 | 201 | 3 | -258 | -52 |
| Other Operating Activity | 410 | 297 | 186 | 76 | 9,568 |
| Operating Cash Flow | $-4,738 | $-3,279 | $-2,246 | $-1,519 | $-4,267 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 11,455 | 11,455 | N/A | N/A | 5,427 |
| Financing Cash Flow | $11,455 | $11,455 | $N/A | $N/A | $5,427 |
| Beginning Cash Position | 11,528 | 11,528 | 11,528 | 11,528 | 10,368 |
| End Cash Position | 18,244 | 19,703 | 9,282 | 10,008 | 11,528 |
| Net Cash Flow | $6,717 | $8,175 | $-2,246 | $-1,519 | $1,160 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,738 | -3,279 | -2,246 | -1,519 | -4,267 |
| Free Cash Flow | -4,738 | -3,279 | -2,246 | -1,519 | -4,267 |